7
Views
2
CrossRef citations to date
0
Altmetric
Review

Sebaceous hyperplasia

&
Pages 91-96 | Published online: 10 Jan 2014

References

  • Belinchon I, Aguilar A, Tardío J, Gallego MA. Areolar sebaceous hyperplasia. Cutis58, 63–64 (1996).
  • Boonchai W, Leenutaphong V. Familial presenile sebaceous gland hyperplasia. J. Am. Acad. Dermatol.36, 120–122 (1997).
  • Zouboulis CC, Baron JM, Böhm M et al. Frontiers in sebaceous gland biology and pathology. Exp. Dermatol.17(6), 542–551 (2008).
  • Boschnakow A, May T, Assaf C, Tebbe B, Zouboulis ChC. Ciclosporin A-induced sebaceous gland hyperplasia. Br. J. Dermatol.149(1), 198–200 (2003).
  • Kumar A, Kossard S. Band-like sebaceous hyperplasia over the penis. Australas. J. Dermatol.40(1), 47–48 (1990).
  • Grimalt R, Ferrando J, Mascaro JM. Premature familial sebaceous hyperplasia: successful response to oral isotretinoin in three patients. J. Acad. Dermatol.37(6), 996–998 (1997).
  • Bader RS, Scarborough DA. Surgical pearl: intralesional electrodesiccation of sebaceous hyperplasia. J. Am. Acad. Dermatol.42(1 Pt 1), 127–128 (2000).
  • No D, McClaren M, Chotzen V, Kilmer SL. Sebaceous hyperplasia treated with a 1450-nm diode laser. Dermatol. Surg.30(3), 382–384 (2004).
  • Thiboutot D. Regulation of human sebaceous glands. J. Invest. Dermatol.123(1), 1–12 (2004).
  • Niemann C. Differentiation of the sebaceous gland. Dermatoendocrinol.1(2), 64–67 (2009).
  • Zouboulis C. The human skin as a hormone target and an endocrine gland. Hormones3, 9–26 (2004).
  • Pilgram GS, van der Meulen J, Gooris GS, Koerten HK, Bouwstra JA. The influence of two azones and sebaceous lipids on the lateral organization of lipids isolated from human stratum corneum. Biochim. Biophys. Acta1511, 244–254 (2001).
  • Oztas P, Polat M, Oztas M, Alli N, Ustun H. Bonbon toffee sign: a new dermatoscopic feature for sebaceous hyperplasia. J. Eur. Acad. Dermatol. Venereol.22(10), 1200–1202 (2008).
  • Simi CM, Rajalakshmi T, Correa M. Clinicopathologic analysis of 21 cases of nevus sebaceous: a retrospective study. Indian J. Dermatol. Venereol. Leprol.74(6), 625–627 (2008).
  • Thomas VD, Swanson NA, Lee KK. Chapter 118. Benign epithelial tumors, hamartomas, and hyperplasias. In: Fitzpatrick’s Dermatology in General Medicine, 7e. Wolff K, Goldsmith LA, Katz SI, Gilchrest B, Paller AS, Leffell DJ (Eds). McGraw Hill, NY, USA (2007).
  • Shalin SC, Lyle S, Calonje E, Lazar AJ. Sebaceous neoplasia and the Muir–Torre syndrome: important connections with clinical implications. Histopathology56(1), 133–147 (2010).
  • Altamura D, Menzies SW, Argenziano G et al. Dermatoscopy of basal cell carcinoma: morphologic variability of global and local features and accuracy of diagnosis. J. Am. Acad. Dermatol.62(1), 67–75 (2010).
  • Eisen DB, Michael DJ. Sebaceous lesions and their associated syndromes: part I. J. Am. Acad. Dermatol.61(4), 549–560 (2009).
  • Zaballos P, Ara M, Puig S, Malvehy J. Dermoscopy of sebaceous hyperplasia. Arch. Dermatol.141(6), 808 (2005).
  • Kim NH, Zell DS, Kolm I, Oliviero M, Rabinovitz HS. The dermoscopic differential diagnosis of yellow lobularlike structures. Arch. Dermatol.144(7), 962 (2008).
  • Bryden AM, Dawe RS, Fleming C. Dermatoscopic features of benign sebaceous proliferation. Clin. Exp. Dermatol.29(6), 676–677 (2004).
  • Zouboulis CC, Adjaye J, Akamatsu H, Moe-Behrens G, Niemann C. Human skin stem cells and the aging process. Exp. Gerontol.43, 986–997 (2008).
  • Zouboulis CC, Schagen S, Alestas T. The sebocyte culture: a model to study the pathophysiology of the sebaceous gland in sebostasis, seborrhoea and acne. Arch. Dermatol. Res.300(8), 397–413 (2008).
  • Zouboulis CC, Boschnakow A. Chronological ageing and photoageing of the human sebaceous gland. Clin. Exp. Dermatol.26(7), 600–607 (2001).
  • Lesnik RH, Kligman LH, Kligman AM. Agents that cause enlargement of sebaceous glands in hairless mice. II. Ultraviolet radiation. Arch. Dermatol. Res.284(2), 106–108 (1992).
  • Kumar P, Marks R. Sebaceous gland hyperplasia and senile comedones: a prevalence study in elderly hospitalized patients. Br. J. Dermatol.117(2), 231–236 (1987).
  • Panteleyev AA, Rosenbach T, Paus R, Christiano AM. The bulge is the source of cellular renewal in the sebaceous gland of mouse skin. Arch. Dermatol. Res.292, 573–576 (2000).
  • Ghazizadeh S, Taichman LB. Multiple classes of stem cells in cutaneous epithelium: a lineage analysis of adult mouse skin. EMBO J.20, 1215–1222 (2001).
  • Horsley V, O’Carroll D, Tooze R et al. Blimp1 defines a progenitor population that governs cellular input to the sebaceous gland. Cell126, 597–609 (2006).
  • Zouboulis CC, Seltmann H, Neitzel H, Orfanos CE. Establishment and characterization of an immortalized human sebaceous gland cell line (SZ95). J. Invest. Dermatol.113, 1011–1020 (1999).
  • Clevers H. Wnt/β-catenin signaling in development and disease. Cell127, 469–480 (2006).
  • Merrill BJ, Gat U, DasGupta R, Fuchs E. Tcf3 and Lef1 regulate lineage differentiation of multipotent stem cells in skin. Genes Dev.15, 1688–1705 (2001).
  • Niemann C, Owens DM, Hulsken J. Birchmeier W, Watt FM. Expression of DeltaNLef1 in mouse epidermis results in differentiation of hair follicle keratinocytes into squamous epidermal cysts and formation of skin tumours. Development129, 95–109 (2002).
  • Takeda H, Lyle S, Lazar AJ, Zouboulis CC, Smyth I, Watt FM. Human sebaceous tumors harbor inactivating mutations in Lef1. Nat. Med.12, 395–397 (2006).
  • Niemann C, Owen DM, Schettina P, Watt FM. Dual role of inactivating Lef1 mutations in epidermis: tumour promotion and specification of tumour type. Cancer Res.67, 2916–2921 (2007).
  • Han G, Li AG, Liang YY et al. Smad7-induced β-catenin degradation alters epidermal appendage development. Dev. Cell.11, 301–312 (2006).
  • Zouboulis CC. Sebaceous gland receptors. Dermatoendocrinol.1(2), 77–80 (2009).
  • Chen WC, Zouboulis CC. Hormones and the pilosebaceous unit. Dermatoendocrinol.1(2), 81–86 (2009).
  • Krause K, Schnitger A, Fimmel S, Glass E, Zouboulis CC. Corticotropin-releasing hormone skin signaling is receptor-mediated and is predominant in the sebaceous glands. Horm. Metab. Res.39, 166–170 (2007).
  • Zouboulis CC, Seltmann H, Hiroi N et al. Corticotropin releasing hormone: an autocrine hormone that promotes lipogenesis in human sebocytes. Proc. Natl Acad. Sci. USA99, 7148–7153 (2002).
  • Bohm M, Schiller M, Stander S et al. Evidence for expression of melanocortin-1 receptor in human sebocytes in vitro and in situ.J. Invest. Dermatol.118, 533–539 (2002).
  • Deplewski D, Rosenfield R. Growth hormone and insulin like growth factors have different effects on sebaceous cell growth and differention. Endocrinology140, 4089–4094 (1999).
  • Fritsch M, Orfanos C, Zouboulis CC. Sebocytes are the key regulators of androgen homeostasis in human skin. J. Invest. Dermatol.116, 793–800 (2001).
  • Thiboutot D, Jabara S, McAllister JM et al. Human skin is a steroidogenic tissue: steroidogenic enzymes and cofactors are expressed in epidermis, normal sebocytes, and an immortalized sebocyte cell line (SEB-1). J. Invest. Dermatol.120, 905–914 (2003).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.